The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar Degeneration

• Main Authors: Ramona M. Haanpää, Noora-Maria Suhonen, Päivi Hartikainen, Anne M. Koivisto, Virpi Moilanen, Sanna-Kaisa Herukka, Tuomo Hänninen, Anne M. Remes
• Format: Article
• Language: English
• Published: Karger Publishers 2015-04-01
• Series: Dementia and Geriatric Cognitive Disorders Extra
• Subjects: Trail Making Test; Aphasia; Cognition; Frontotemporal dementia; Frontotemporal lobar degeneration; CERAD neuropsychological battery
• Online Access: http://www.karger.com/Article/FullText/380815

Background/Aims: The diagnosis of frontotemporal lobar degeneration (FTLD) is based on neuropsychological examination in addition to clinical symptoms and brain imaging. There is no simple, validated, cognitive tool available in screening for FTLD. The Consortium to Establish a Registry for Alzheimer's Disease neuropsychological battery (CERAD-NB) was originally devised to identify the early cognitive changes related to Alzheimer's disease (AD). Our aim was to investigate the utility of the CERAD-NB in FTLD. Methods: Patients with FTLD (n = 95) and AD (n = 90) were assessed with the CERAD-NB, Trail Making Test parts A and B and single-letter Phonemic Fluency. Results: FTLD patients were more severely impaired in the Verbal Fluency subtest in the CERAD-NB and Trail Making Test part A compared to AD patients. In addition, AD patients were more impaired in memory subtests compared to FTLD patients. Conclusion: The CERAD-NB may be a useful tool in screening for FTLD. Impaired performance in Verbal Fluency with moderately well-preserved Delayed Recall and Memory Tests may help in identifying patients with probable FTLD and discriminating FTLD from AD. Adding the Trail Making Test to the battery might enhance its value as a screening instrument for FTLD.